# CREBBP
## Overview
CREBBP mutations are highly prevalent in both DLBCL and FL. These mutations often affect the histone acetyltransferase (HAT) domain, crucial for regulating gene expression through chromatin modification, or generate a truncated protein.<sup>1</sup> This gene has some recurrent sites of mutations (hotspots), mostly in the HAT domain. 

## Relevance tier by entity

|Entity|Tier|Description                           |
|:------:|:----:|--------------------------------------|
|DLBCL |1   |high-confidence DLBCL gene            |
|FL    |1   |high-confidence FL gene               |
|BL    |2   |association with BL is tenuous|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source               |frequency (%)|
|:------:|:---------------------:|:-------------:|
|DLBCL |GAMBL genomes        |25.81        |
|DLBCL |Schmitz cohort       |17.87        |
|DLBCL |Reddy cohort         |12.11        |
|DLBCL |Chapuy cohort        |16.67        |
|FL    |GAMBL genomes        |65.13        |
|BL    |GAMBL genomes+capture| 6.00        |
|BL    |Thomas cohort        | 3.00        |
|BL    |Panea cohort         |12.90        |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   | 1.357          |  3.999         |
|DLBCL |No  |Yes                  |13.231          | 65.302         |
|FL    |No  |Yes                  |43.869          |112.938         |


> [!NOTE]
> First described in BL in 2012 by [Love C](https://pubmed.ncbi.nlm.nih.gov/23143597). First described in DLBCL in 2011 by [Pasqualucci L](https://pubmed.ncbi.nlm.nih.gov/21390126). First described in FL in 2011 by [Morin RD](https://pubmed.ncbi.nlm.nih.gov/21796119)


 ## CREBBP Hotspots

| Chromosome |Coordinate (hg19) | ref>alt | HGVSp | 
 | :---:| :---: | :--: | :---: |
| chr16 | 3788618 | G>A | R1446C |
| chr16 | 3788617 | C>T | R1446H |
| chr16 | 3788617 | C>A | R1446L |
| chr16 | 3788606 | A>T | Y1450N |
| chr16 | 3788606 | A>C | Y1450D |
| chr16 | 3788605 | T>G | Y1450S |
| chr16 | 3788605 | T>C | Y1450C |
| chr16 | 3788596 | A>G | I1453T |
| chr16 | 3788594 | G>T | L1454I |
| chr16 | 3788593 | A>C | L1454R |
| chr16 | 3786715 | A>T | L1499Q |
| chr16 | 3786715 | A>G | L1499P |
| chr16 | 3786715 | A>C | L1499R |
| chr16 | 3786710 | C>A | E1501* |
| chr16 | 3786707 | A>T | W1502R |
| chr16 | 3786707 | A>G | W1502R |
| chr16 | 3786705 | C>T | W1502* |
| chr16 | 3786705 | C>G | W1502C |
| chr16 | 3786705 | C>A | W1502C |
| chr16 | 3786704 | A>T | Y1503N |
| chr16 | 3786704 | A>G | Y1503H |
| chr16 | 3786704 | A>C | Y1503D |
| chr16 | 3786703 | T>G | Y1503S |
| chr16 | 3786703 | T>A | Y1503F |
| chr16 | 3786691 | A>G | L1507P |

View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CREBBP_protein.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CREBBP_protein_hg38.html)

![image](images/proteinpaint/CREBBP_NM_004380.svg)

View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/CREBBP.html)  or [hg38](https://morinlab.github.io/LLMPP/GAMBL/CREBBP_hg38.html)

![image](images/proteinpaint/CREBBP.svg)

## References
1. *Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L., Lerach, S., Tang, H., Ma, J., Rossi, D., Chadburn, A., Murty, V., Mullighan, C., Gaidano, G., Rabad√°n, R., Brindle, P., & Dalla-Favera, R. (2010). Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature, 471, 189 - 195. https://doi.org/10.1038/nature09730.*
